Business Wire

Christie’s Global Auction Channel Sales Total £3.9 Billion/US$5.0 Billion In 2019

21.12.2019 02:17:00 EET | Business Wire | Press release

Share

Christie’s announced auction channel sales of £3.9 billion (US$5 billion) for 2019.

Key highlights for the year included:

  • A new top price for any living artist at auction, achieved with Jeff Koon’s Rabbit, which realized US$91,075,000 at Christie’s New York in May 2019.
  • Numerous record prices in 2019, including top prices for artworks and objects sold in London (David Hockney, Henry Geldzahler and Christopher Scott, for £37,661,248/US$49,521,696), Hong Kong (Sanyu, Five Nudes, for HK$303,984,992/US$38,848,420) and Geneva (Patek Philippe Grandmaster Chime ref. 6300A for ONLY WATCH for CHF31,000,000/US$31,244,094). In Paris Nicolas de Staël’s Parc des Princes realized €20,000,000/US$22,254,368, and set a record for the artist and was the top price for any lot sold at Christie’s Paris this year.
  • Christie’s remained the auction house of choice for major private and estate collections, achieving the top three results for named collections in 2019 with Masterpieces from the Collection of S.I. Newhouse, The Robert B. and Beatrice C. Mayer Family Collection, and Maharajas and Mughal Magnificence.
  • Strong results were also achieved for the collections of notable collectors David Gilmour, Drue Heinz, the Irving Collection, James and Marilynn Alsdorf, Terry Allen Kramer, Eileen and I.M. Pei, Richard L. Weisman, George Michael, the Clarke Collection, Ron and Diane Disney Miller, the Matthys-Colle Collection, works from the UniCredit Group, Jeremy Lancaster, and masterpieces from a Rothschild Collection.

Guillaume Cerutti, Chief Executive Officer, commented: “Amid a challenging global environment, demand for art remains strong and is reflected in our 2019 results, especially for Modern and Contemporary art. In the last month alone, we were particularly pleased by the results achieved in New York for Christie’s 20th Century Art week, in Hong Kong for our Autumn sale series—despite a heightened political context—and in London during our Classic Week sales, including Old Masters. We are looking forward to continuing the momentum in 2020.”

For more on Christie’s top 2019 moments, please visit our online feature here.

Christie’s will publish full 2019 results, inclusive of private and e-commerce channel sales, in early 2020.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PRESS:
Nicky Eaton
London | presslondon@christies.com
New York | communicationsamericas@christies.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

KfW, Germany’s largest national promotional bank, future-proofs regulatory reporting, by migrating to Regnology Reporting Hub (RRH)19.5.2026 09:33:00 EEST | Press release

Regnology, a leading provider at the intersection of regulatory, risk, and supervisory technology, today announced that KfW Bankengruppe (KfW) is advancing its long-term partnership with the company by electing to migrate to the next-generation Regulatory Reporting Hub (RRH). The solution will be delivered as a cloud-native service on Rcloud, Regnology’s high-performance cloud architecture layer. This strategic move to the modern RRH platform future-proofs the mission-critical reporting functions for one of the world's leading promotional banks. Headquartered in Frankfurt am Main, KfW is a public‑law institution dedicated to supporting sustainable economic, social and ecological development in Germany, across Europe and globally. Regnology’s foresight led to the 2023 launch of Rcloud, its state-of-the-art architecture layer built on Google Cloud, enabling next‑generation solutions like RRH to operate with the full power of cloud-native design delivering the clear operational and strate

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth19.5.2026 09:00:00 EEST | Press release

ATB Therapeutics (“ATB” or the “Company”), a biopharmaceutical company advancing next-generation antibody-based therapies for oncology and immunology, today announced the appointment of Mark Throsby, PhD, as Chief Executive Officer. The leadership transition marks an important milestone as the Company continues its evolution from a startup into a development-stage biopharmaceutical company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513198633/en/ ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth Mark Throsby has served as Executive Chairman and Chief Scientific Officer since 2024, during which time he supported the Company’s growth, including the successful closing of its Series A financing, the expansion of the scientific team, and the advancement of its therapeutic programs. In his new role, he will lead ATB’s strategy and senior leadership team as the Company prepares to enter clinical deve

TREASoURcE Shows How Circular Economy Solutions Can Move Beyond Pilots Across Sectors and Regions19.5.2026 08:00:00 EEST | Press release

Across Europe, many circular economy solutions struggle to move beyond isolated pilots and into real-world deployment at scale. New approaches are needed that combine technical feasibility, market relevance and citizen engagement, while remaining adaptable to local contexts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260518914041/en/ TREASoURcE addressed circular economy challenges across energy, plastics and biobased side streams, combining technical solutions with stakeholder and citizen engagement. The EU-funded TREASoURcE project provides evidence that systemic, citizen-engaged circular economy solutions can be developed, tested and prepared for replication across regions. Using a common regional approach, the project combined real-life demonstrations, cross-value chain collaboration and early consideration of transferability to translate circular economy concepts into practical solutions in the fields of energy, mat

Shufti Recognised as Dual Leader in Liminal's 2026 Age Verification and Age Estimation Indexes, with Exceptional Ratings Across Both Benchmarks19.5.2026 08:00:00 EEST | Press release

Shufti has been named a Leader in both the Age Verification and Age Estimation categories of Liminal’s 2026 Index Report, receiving an Exceptional rating for Market Presence across both. Liminal, an actionable intelligence firm, evaluates identity verification vendors across Product Execution, Strategy, and Market Presence, assessing scalability, accuracy, fraud resistance, innovation, and user experience. Out of 189 vendors assessed in the Age Verification Index, only 17 achieved Leader status. Shufti was among them and exceeded the leadership threshold with a 64% Product Execution score and a 92% Strategy score. In Age Estimation, Shufti again ranked among 17 Leaders from 80 evaluated vendors, exceeding leadership thresholds across core evaluation pillars, alongside an Exceptional Market Presence rating in both categories. “Achieving Leader status in both Age Estimation and Age Verification reflects that our solutions are built for accurate, scalable, and privacy-first age assurance

Azafaros Strengthens Leadership Team With Appointment of Amy Sullivan as Chief Financial Officer19.5.2026 08:00:00 EEST | Press release

Azafaros, a private company building a portfolio to become a leader in Lysosomal Storage Disorders and focused on addressing neurological symptoms, today announced that Amy Sullivan has joined the company as Chief Financial Officer. Ms. Sullivan brings more than 30 years’ experience in the life sciences sector, with expertise in capital raising, corporate strategy and communications. She joins Azafaros from IO Biotech, where she served as Chief Financial Officer. “Amy is a highly accomplished financial leader with a strong track record of supporting growth-stage biotech companies,” said Stefano Portolano, Chief Executive Officer at Azafaros. “Her expertise in financing, strategic positioning and transaction execution will be instrumental as we advance our Phase 3 studies with nizubaglustat and continue to build Azafaros as we prepare to file for drug marketing authorization and launch in GM1/GM2 and NPC.” “I am excited to join Azafaros at such an important stage in the company’s develo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye